CN Stock MarketDetailed Quotes
603363 Fujian Aonong Biological Technology Group Incorporation
- 3.44
- -0.02-0.58%
Market Closed Sep 27 15:00 CST
2.99BMarket Cap-885P/E (TTM)
3.47High3.42Low264.58KlotVolume3.45Open3.46Pre Close90.99MTurnover3.59%Turnover RatioLossP/E (Static)870.27MShares8.7552wk High-1.94P/B2.54BFloat Cap2.3852wk Low3.63Limit Up737.46MShs Float28.49Historical High3.29Limit Down1.45%Amplitude2.38Historical Low--Dividend TTM3.44Avg Price165.56KlotAsk--Div YieldTTM100Lot Size91.72KlotBid
Fujian Aonong Biological Technology Group Incorporation Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -56.56%4.4B | -53.48%2.24B | -10.57%19.49B | -1.14%15.2B | 14.07%10.13B | 11.27%4.81B | 19.74%21.79B | 16.20%15.38B | 6.74%8.88B | 8.94%4.32B |
| Refunds of taxes and levies | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.77%1.36K | -99.77%1.36K | ---- |
| Cash received relating to other operating activities | 206.00%623.75M | -9.41%86.71M | 560.13%2.53B | -10.47%337.28M | 19.34%203.84M | -53.35%95.72M | -18.14%382.98M | 1.06%376.73M | -41.63%170.81M | 36.08%205.21M |
| Cash inflows from operating activities | -51.38%5.02B | -52.62%2.33B | -0.71%22.01B | -1.36%15.54B | 14.17%10.33B | 8.34%4.91B | 18.78%22.17B | 15.78%15.76B | 5.09%9.05B | 9.94%4.53B |
| Goods services cash paid | -58.20%3.7B | -53.90%1.86B | -12.65%16.87B | -6.13%13.25B | 8.28%8.84B | 3.45%4.04B | 20.26%19.32B | 20.57%14.11B | 12.24%8.17B | 9.90%3.91B |
| Staff behalf paid | -37.30%476.76M | -30.98%279.4M | -5.27%1.4B | 2.88%1.11B | 7.75%760.35M | 20.87%404.82M | 10.26%1.48B | 10.98%1.08B | 5.83%705.66M | 8.17%334.93M |
| All taxes paid | -45.27%37.3M | -54.34%18.15M | 8.35%108.27M | 39.64%88.16M | 67.08%68.14M | 80.43%39.76M | 15.61%99.93M | -1.96%63.13M | -11.01%40.79M | -8.81%22.03M |
| Cash paid relating to other operating activities | 111.36%623.41M | 13.84%193.79M | 332.60%2.65B | -10.14%429.68M | -7.58%294.95M | 27.03%170.22M | -6.03%612.35M | -8.08%478.19M | -13.36%319.13M | -27.17%134M |
| Cash outflows from operating activities | -51.50%4.83B | -49.43%2.35B | -2.22%21.03B | -5.45%14.88B | 7.95%9.97B | 5.88%4.66B | 18.56%21.51B | 18.63%15.74B | 10.47%9.23B | 7.98%4.4B |
| Net cash flows from operating activities | -48.01%187.81M | -111.36%-28.7M | 48.27%984.01M | 3,495.99%661.29M | 293.86%361.22M | 89.26%252.71M | 26.58%663.64M | -94.62%18.39M | -174.22%-186.33M | 172.44%133.52M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 681.28%28.15M | 20,771.14%43.05M | -40.26%5.45M | -32.41%4.61M | -16.68%3.6M | -95.23%206.26K | --9.12M | --6.82M | --4.32M | 2,062.15%4.32M |
| Cash received from returns on investments | 62.03%264.28K | 36.21%210K | 10,952.82%129.58K | 13,813.52%163.12K | 13,812.29%163.1K | 13,072.50%154.17K | -99.89%1.17K | -99.87%1.17K | -99.87%1.17K | -99.63%1.17K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 2,903.41%149.13M | 6,846.03%142.73M | 465.49%78.18M | -38.72%7.23M | -32.73%4.97M | 1,563.28%2.05M | 14.64%13.83M | 169.37%11.81M | 222.14%7.38M | -93.13%123.54K |
| Net cash received from disposal of subsidiaries and other business units | -75.49%29.85M | -83.84%8.98M | 7,955.62%251.83M | 4,115.37%131.78M | --121.78M | --55.56M | -54.02%3.13M | -34.07%3.13M | ---- | ---- |
| Cash received relating to other investing activities | -83.01%4.57M | -75.67%4.55M | -87.64%31.15M | -87.64%30.9M | -9.73%26.9M | 115.17%18.71M | -61.23%252.14M | -55.19%250.06M | -62.62%29.8M | 75.18%8.69M |
| Cash inflows from investing activities | 34.66%211.96M | 160.20%199.52M | 31.82%366.74M | -35.73%174.69M | 279.27%157.41M | 483.41%76.68M | -58.49%278.21M | -52.15%271.81M | -52.64%41.5M | 80.65%13.14M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -46.41%174.8M | -38.08%137.63M | -65.86%511.77M | -64.45%416.58M | -55.72%326.21M | -45.10%222.28M | -44.66%1.5B | -48.42%1.17B | -62.50%736.69M | -65.11%404.86M |
| Cash paid to acquire investments | ---- | ---- | -98.44%1.68M | ---- | ---- | -90.27%5M | 444.29%107.53M | 212.22%59.42M | 401.91%56.62M | 12,750.00%51.4M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | -12.88%56.54M | -47.97%28.13M | -46.89%24.03M | -13.66%17.48M | -7.49%64.89M | 3.30%54.07M | 4.66%45.24M | 50.94%20.24M |
| Cash paid relating to other investing activities | -98.65%1.58M | -94.38%1.27M | -61.67%118.83M | -62.40%117.02M | -52.22%116.91M | 126.61%22.57M | -54.27%310.06M | -44.71%311.21M | 178.99%244.7M | 88.63%9.96M |
| Cash outflows from investing activities | -62.24%176.38M | -48.04%138.9M | -65.24%688.82M | -64.81%561.74M | -56.87%467.15M | -45.05%267.32M | -43.01%1.98B | -45.06%1.6B | -48.58%1.08B | -58.76%486.46M |
| Net cash flows from investing activities | 111.49%35.58M | 131.80%60.62M | 81.09%-322.08M | 70.78%-387.05M | 70.27%-309.74M | 59.72%-190.64M | 39.31%-1.7B | 43.34%-1.32B | 48.40%-1.04B | 59.62%-473.32M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | 66.21%33.03M | 177.92%30.6M | -97.08%47.28M | -97.58%38.91M | -98.70%19.88M | -71.57%11.01M | 33.63%1.62B | 748.48%1.61B | 806.19%1.53B | -21.91%38.73M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | 66.21%33.03M | 177.92%30.6M | -74.45%47.28M | -77.82%38.91M | -79.85%19.88M | -71.57%11.01M | 26.34%185.04M | 55.58%175.42M | 6.97%98.64M | -21.91%38.73M |
| Cash from borrowing | -91.05%275.65M | -88.47%149.05M | -0.53%5.54B | 2.23%4.71B | -10.63%3.08B | -37.43%1.29B | 6.20%5.56B | -4.68%4.61B | -5.46%3.45B | -15.16%2.07B |
| Cash received relating to other financing activities | -3.99%288.25M | -71.70%58.36M | 110.76%2.12B | 5.11%579.22M | 10.50%300.23M | -30.46%206.22M | 30.10%1.01B | -0.73%551.06M | -35.45%271.7M | 41.66%296.53M |
| Cash inflows from financing activities | -82.45%596.93M | -84.24%238.01M | -5.92%7.7B | -21.26%5.33B | -35.23%3.4B | -37.12%1.51B | 13.36%8.19B | 21.30%6.77B | 23.93%5.25B | -10.87%2.4B |
| Borrowing repayment | -86.76%390.65M | -88.95%161.57M | 9.93%5.74B | 18.08%4.69B | 0.59%2.95B | -12.87%1.46B | 48.95%5.22B | 53.36%3.98B | 72.48%2.93B | 66.96%1.68B |
| Dividend interest payment | -67.68%59.04M | -54.48%41.03M | -11.35%331.27M | -1.42%262.72M | -1.40%182.69M | 8.09%90.14M | -13.59%373.67M | -24.54%266.5M | -31.37%185.29M | 15.86%83.4M |
| -Including:Cash payments for dividends or profit to minority shareholders | -53.87%12.98M | 12.14%12M | -29.52%36.4M | 45.14%30.32M | 34.73%28.14M | 485.35%10.7M | -40.40%51.65M | -71.81%20.89M | -61.81%20.89M | -90.77%1.83M |
| Cash payments relating to other financing activities | -78.31%147.64M | -69.37%75.21M | 101.17%2.76B | -1.53%1.07B | -4.65%680.66M | -26.34%245.57M | 26.47%1.37B | 32.80%1.09B | 23.23%713.89M | 26.70%333.4M |
| Cash outflows from financing activities | -84.34%597.33M | -84.55%277.81M | 26.78%8.83B | 13.10%6.03B | -0.48%3.81B | -14.18%1.8B | 38.70%6.97B | 41.58%5.33B | 50.30%3.83B | 56.31%2.1B |
| Net cash flows from financing activities | 99.90%-399.65K | 86.18%-39.8M | -192.64%-1.13B | -148.58%-698.45M | -129.23%-414.11M | -194.01%-288M | -44.53%1.22B | -20.77%1.44B | -15.97%1.42B | -77.37%306.36M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 90.85%-10.1K | -96.58%6.9K | -0.12%-2.06M | 54.69%-1.22M | -591.55%-110.36K | 88.67%201.68K | -1,687.35%-2.05M | -6,404.02%-2.69M | 151.54%22.45K | 467.27%106.9K |
| Net increase in cash and cash equivalents | 161.47%222.98M | 96.52%-7.87M | -363.50%-470.46M | -430.04%-425.42M | -292.24%-362.74M | -577.22%-225.74M | 316.31%178.55M | 171.09%128.9M | 330.05%188.69M | -114.44%-33.33M |
| Add:Begin period cash and cash equivalents | -75.57%152.05M | -75.57%152.05M | 40.22%622.51M | 40.22%622.51M | 40.22%622.51M | 40.22%622.51M | -15.68%443.96M | -15.68%443.96M | -15.68%443.96M | -15.68%443.96M |
| End period cash equivalent | 44.37%375.03M | -63.66%144.18M | -75.57%152.05M | -65.60%197.08M | -58.94%259.77M | -3.38%396.77M | 40.22%622.51M | 65.96%572.86M | 42.34%632.65M | -45.78%410.63M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | Rong Shing Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Shing Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data